Counterfeiting Bill Would Give FDA Recall Authority, Boost Funding
Executive Summary
FDA would receive authority to recall products it believes pose a health risk under a bill introduced by Rep. Steve Israel (D-N.Y.)
You may also be interested in...
Anti-Counterfeiting Interim Step Should Be Paper Pedigree, PhRMA Says
Drug products should contain paper pedigrees as an interim anti-counterfeit measure, the Pharmaceutical Research & Manufacturers of America said at FDA's Oct. 15 Anti-Counterfeit Drug Initiative public meeting in Bethesda, Md
Anti-Counterfeiting Interim Step Should Be Paper Pedigree, PhRMA Says
Drug products should contain paper pedigrees as an interim anti-counterfeit measure, the Pharmaceutical Research & Manufacturers of America said at FDA's Oct. 15 Anti-Counterfeit Drug Initiative public meeting in Bethesda, Md
FDA Counterfeiting Task Force To Look At Tighter Wholesaler Licensing
An FDA task force could look to Florida's new drug wholesaler licensing requirements as a model that all states should adopt to combat counterfeiting